This announcement is a separate document:
杭州天目山药业股份有限公司2023年度向特定对象发行A股股票方案论证分析报告
Verification and analysis report on Hangzhou Tianmushan Pharmaceutical Co., Ltd.\'s 2023 plan to issue A-shares to specific targets
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.